Akshat Jain: Proud to Announce the Publication of Advances in Sickle Cell Disease
Akshat Jain, Hematology Pediatric Workforce Task Force at American Society of Hematology, shared a post on LinkedIn:
“I am proud to announce the publication of Advances in Sickle Cell Disease, a new international medical textbook that brings the world’s perspective and insights from the corners that usually don’t find representation in academia that well. One stop shop review text on Sickle Cell Disease.
Advances in Sickle Cell Disease brings together international perspectives spanning epidemiology and disease biology, transfusion medicine, advances in disease-modifying therapies, hematopoietic stem-cell transplantation, gene editing and emerging gene-based approaches, patient-centered care, and the global challenge of translating discovery into everyday practice.
The volume is peer-reviewed and open access, with international contributors and permanent online availability.
- Published: 07 October 2026
- ISBN: 978-1-80631-273-3
- Print ISBN: 978-1-80631-274-0
What has been particularly gratifying is the immediate academic engagement.
- 687+ chapter downloads
- 2 Dimensions citations
- International open-access readership
- Discoverable through major scholarly indexing/citation infrastructure
- Print edition available through Amazon — all essentially at launch.
The book includes work already published as peer-reviewed chapters on topics ranging from gene editing and hematopoietic stem-cell transplantation to public-health program development, reflecting the deliberate bridge between molecular innovation and population health.
Those numbers matter not as a measure of prestige alone, but because every download represents the possibility that knowledge moves—from a researcher to a new question, from an educator to a classroom, from a clinician to a bedside, and ultimately from scientific discovery to a person living with sickle cell disease.
This book is intended not only for hematologists. I hope it reaches physicians, scientists, geneticists, public-health leaders, nurses, trainees, medical educators, policymakers, biotechnology innovators, global-health organizations, patient advocates.
I invite colleagues around the world to read it, teach it, cite it, challenge it, share it—and use it to start the next important conversation in sickle cell disease, Now orderable on Amazon.”
Find more posts featuring Akshat Jain on Hemostasis Today.
-
Oct 8, 2026, 23:27Shayan Mohammadmoradi: Happy to Be Back at the Midwest Platelet Conference for Its 20th Meeting
-
Oct 8, 2026, 23:18Lorena Arranz: Honoured to Contribute to the 6th Global MPN Symposium
-
Oct 8, 2026, 23:06Denis Oduor: Serving Citizens and Saving Lives Through Blood Donation During National Customer Service Week 2026
-
Oct 8, 2026, 22:51Jan Hartmann: Speaking on Global Trends in Plasma Collection at the 50th Meeting of the Japanese Society of Blood Services
-
Oct 8, 2026, 22:49Ed Shovelin: Extending the Platelet Aggregation Testing Window to 72 Hours
-
Oct 8, 2026, 22:48Abdulla A. Damluji: Anticancer Drugs and Thrombosis Mechanisms, Risk Factors, and Prevention
-
Oct 8, 2026, 22:46Miguel Escobar: My Research on Oral Health and Hemophilia
-
Oct 8, 2026, 22:44ISTH 2027 Abstract Submission Opens November 23
-
Oct 8, 2026, 22:41Kunihiro Hattori Pioneering Research for People With Hemophilia A – The Albert and Mary Lasker Foundation